LakeShore Biopharma Co., Ltd. - *W EXP 03/15/202 (LSBPW)

CUSIP: G9845F117

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class
Equity / *W EXP 03/15/202
Total 13F shares
10,050
Share change
-4,947,340
Total reported value
$32
Price per share
$0.00
Number of holders
2
Value change
-$196,360
Number of sells
14

Quarterly Holders Quick Answers

What is CUSIP G9845F117?
CUSIP G9845F117 identifies LSBPW - LakeShore Biopharma Co., Ltd. - *W EXP 03/15/202 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of LakeShore Biopharma Co., Ltd. - *W EXP 03/15/202 (LSBPW) as of Q3 2025

As of 30 Sep 2025, LakeShore Biopharma Co., Ltd. - *W EXP 03/15/202 (LSBPW) was held by 2 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 10,050 shares. The largest 2 holders included Ancora Advisors LLC and HGC Investment Management Inc.. This page lists 2 institutional shareholders reporting positions in this security for the Q3 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.